Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Jazz Pharmaceuticals plc market cap for the quarter ending 2026-07-27 was $16.58B, a 135.31% increase year-over-year.
Jazz Pharmaceuticals plc market cap for the quarter ending 2026-04-28 was $12.8B, a 77.51% increase year-over-year.
Jazz Pharmaceuticals plc market cap for the quarter ending 2026-04-15 was $12.5B, a 97.07% increase year-over-year.
Jazz Pharmaceuticals plc market cap for the quarter ending 2026-02-17 was $10.34B, a 26.12% increase year-over-year.
Jazz Pharmaceuticals plc market cap for fiscal 2026 was $16.58B.
Jazz Pharmaceuticals plc market cap for fiscal 2025 was $10.44B, a 39.87% increase from fiscal 2024.
Jazz Pharmaceuticals plc market cap for fiscal 2024 was $7.47B, a 2.49% decline from fiscal 2023.
Jazz Pharmaceuticals plc market cap for fiscal 2023 was $7.66B, a 23.96% decline from fiscal 2022.